Table 1. Demographic and baseline characteristics of each cohort.
Data are presented as mean ± SD.
| Drug dose (105 units) |
UTI group | Placebo (n = 9) |
Total (n = 51) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 (n = 2) |
6 (n = 2) |
12 (n = 4) |
20 (n = 4) |
30 (n = 6) |
45 (n = 6) |
60 (n = 6) |
70 (n = 6) |
80 (n = 6) |
Total (n = 42) |
|||
| Male | 1 | 1 | 2 | 2 | 3 | 4 | 4 | 4 | 6 | 27 | 8 | 35 |
| Female | 1 | 1 | 2 | 2 | 3 | 2 | 2 | 2 | 0 | 15 | 1 | 16 |
| Age (year) | 24.5±6.4 | 34.0±2.8 | 31.8±6.8 | 24.3±2.4 | 26.2±2.5 | 26.2±5.9 | 26.2±7.7 | 26.5±4.9 | 28.5±4.7 | 27.2±5.4 | 24.8±3.5 | 26.8±5.2 |
| Height (cm): | 164.8±5.2 | 162.2±12 | 161.1±3.4 | 165.6±5.3 | 161.3±10 | 171.2±10 | 170.2±8.6 | 164.2±4.3 | 171.5±5.4 | 166.4±8.2 | 170.2±3.4 | 167.1±7.7 |
| Weight (kg): | 53.3±2.4 | 60.0±8.5 | 58.8±3.7 | 62.7±9.3 | 56.4±4.2 | 64.8±3.2 | 61.2±6.5 | 60.0±7.8 | 63.0±6.1 | 60.6±6.3 | 62.4±7.1 | 60.9±6.4 |
| BMI (kg·m-2) | 19.7±0.4 | 22.8±0.4 | 22.7±1.2 | 22.8±2.2 | 21.8±2.3 | 22.2±2.2 | 21.1±1.1 | 22.2±2.8 | 21.5±2.6 | 21.9±2.0 | 21.5±2.4 | 21.8±2.1 |
Abbreviations: BMI, body mass index; SD, standard deviation.